Literature DB >> 22301505

Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease.

Norma Christine Grandi1, Hermann Brenner, Harry Hahmann, Bernd Wüsten, Winfried März, Dietrich Rothenbacher, Lutz Philipp Breitling.   

Abstract

OBJECTIVE: High serum calcium and phosphate levels have been linked to cardiovascular diseases and all-cause mortality but evidence from longitudinal studies is scarce, especially among patients with pre-existing coronary heart disease. The association between baseline calcium and phosphate and prognosis was examined in a cohort study of patients with stable coronary heart disease.
METHODS: Serum calcium and phosphate were measured in a cohort of initially 1206 patients undergoing a 3 week rehabilitation programme after an acute cardiovascular event and subsequently being followed-up for 8 years. Multivariate Cox regression was employed to assess the association of quartiles and continuous levels of calcium and phosphate with secondary cardiovascular events and all-cause mortality.
RESULTS: No significant risk elevations were observed for secondary cardiovascular event incidence in models adjusted for a variety of potential confounders. High calcium levels, however, were strongly associated with mortality risk in adjusted models (HR(Q4vsQ1)=2.39 (1.22 to 4.66)). In additional multivariable analyses, the calcium/albumin ratio was predictive for all-cause mortality (HR(Q4vsQ1)=2.66 (1.35 to 5.22)) and marginally predictive for cardiovascular event incidence (HR(Q4vsQ1)=1.74 (1.00 to 3.05)).
CONCLUSIONS: Calcium and the ratio of calcium with albumin, its major binding protein, were strongly associated with all-cause mortality among patients with coronary heart disease. The underlying mechanisms and the clinical implications of these findings deserve further study.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22301505     DOI: 10.1136/heartjnl-2011-300806

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  18 in total

Review 1.  The role of calcium in the prevention of cardiovascular disease--a review of observational studies and randomized clinical trials.

Authors:  Susanne Rautiainen; Lu Wang; JoAnn E Manson; Howard D Sesso
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

Review 2.  Almanac 2013: stable coronary artery disease.

Authors:  Shahed Islam; Adam Timmis
Journal:  Wien Klin Wochenschr       Date:  2013-12       Impact factor: 1.704

3.  Age-associated alterations of cardiac structure and function in the female F344xBN rat heart.

Authors:  Jacqueline Fannin; Kevin M Rice; Srininvas Thulluri; Lucy Dornon; Ravi Kumar Arvapalli; Paulette Wehner; Eric R Blough
Journal:  Age (Dordr)       Date:  2014-07-27

4.  Calcium levels on admission and before discharge are associated with mortality risk in hospitalized patients.

Authors:  Amit Akirov; Alexander Gorshtein; Ilana Shraga-Slutzky; Ilan Shimon
Journal:  Endocrine       Date:  2017-06-30       Impact factor: 3.633

5.  Serum Calcium and Risk of Sudden Cardiac Arrest in the General Population.

Authors:  Hirad Yarmohammadi; Audrey Uy-Evanado; Kyndaron Reinier; Carmen Rusinaru; Harpriya Chugh; Jonathan Jui; Sumeet S Chugh
Journal:  Mayo Clin Proc       Date:  2017-09-21       Impact factor: 7.616

6.  Possible association between serum alkaline phosphatase concentration and thoracicacute aortic dissection.

Authors:  Ming Yu; Juan Ding; Long Zhao; Xiang Huang; Ke-Zhong Ma
Journal:  Int J Clin Exp Med       Date:  2015-09-15

7.  Association of bone metabolism markers with coronary atherosclerosis and coronary artery disease in postmenopausal women.

Authors:  Yan Ling; Zhen Wang; Bingjie Wu; Xin Gao
Journal:  J Bone Miner Metab       Date:  2017-06-22       Impact factor: 2.626

8.  Postoperative hyperphosphatemia significantly associates with adverse survival in colorectal cancer patients.

Authors:  Zhong Ye; Juan P Palazzo; Liz Lin; Yinzhi Lai; Fran Guiles; Ronald E Myers; Jin Han; Jinliang Xing; Hushan Yang
Journal:  J Gastroenterol Hepatol       Date:  2013-09       Impact factor: 4.029

9.  Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease.

Authors:  Michael E Seifert; Lisa de las Fuentes; Marcos Rothstein; Dennis J Dietzen; Andrew J Bierhals; Steven C Cheng; Will Ross; David Windus; Víctor G Dávila-Román; Keith A Hruska
Journal:  Am J Nephrol       Date:  2013-08-07       Impact factor: 3.754

10.  Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links.

Authors:  A Fisher; W Srikusalanukul; M Davis; P Smith
Journal:  Clin Interv Aging       Date:  2013-02-25       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.